Berger Mark Stanley
Insider CIK 1700283 · ATNM Chief Medical Officer · GNPX Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| GNPX Genprex, Inc. | F Tax w/h | 2026-02-27 | 2026-02-27 | 7,168 | $2.00 | $14.3K | 21,692 | SEC↗ |
| GNPX Genprex, Inc. | A Award | 2025-12-22 | 2025-12-23 | 28,500 | — | $0 | 28,860 | SEC↗ |
| GNPX Genprex, Inc. | F Tax w/h | 2025-06-30 | 2025-07-01 | 4,500 | $0.23 | $1.0K | 17,971 | SEC↗ |
| GNPX Genprex, Inc. | F Tax w/h | 2025-02-18 | 2025-02-19 | 585 | $0.41 | $240 | 22,471 | SEC↗ |
| GNPX Genprex, Inc. | A Award | 2024-12-05 | 2024-12-06 | 18,250 | — | $0 | 23,056 | SEC↗ |
| GNPX Genprex, Inc. | F Tax w/h | 2024-02-18 | 2024-02-21 | 1,319 | $4.40 | $5.8K | 4,806 | SEC↗ |
| GNPX Genprex, Inc. | A Award | 2023-02-18 | 2023-02-22 | 245,000 | — | $0 | 245,000 | SEC↗ |
| GNPX Genprex, Inc. | A Award deriv | 2022-02-04 | 2022-02-08 | 98,750 | — | $0 | 98,750 | SEC↗ |
| GNPX Genprex, Inc. | A Award deriv | 2021-09-27 | 2021-09-28 | 550,000 | — | $0 | 550,000 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | A Award deriv | 2021-09-01 | 2021-09-03 | 67,164 | — | $0 | 67,164 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | A Award deriv | 2020-08-12 | 2020-08-14 | 46,667 | — | $0 | 46,667 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | A Award deriv | 2019-07-12 | 2019-07-16 | 400,000 | $0.23 | $92.0K | 400,000 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | X Exercise | 2019-03-05 | 2019-03-07 | 3,500 | $0.60 | $2.1K | 22,500 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | A Award deriv | 2018-07-13 | 2018-07-17 | 250,000 | $0.78 | $195.0K | 250,000 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | J Other deriv | 2018-03-06 | 2018-03-19 | 3,500 | $0.50 | $1.8K | 3,500 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | J Other deriv | 2018-03-06 | 2018-03-19 | 10,500 | $0.50 | $5.3K | 10,500 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | J Other | 2018-03-06 | 2018-03-19 | 14,000 | $0.50 | $7.0K | 19,000 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | P Buy | 2017-06-15 | 2017-06-15 | 5,000 | $1.11 | $5.6K | 5,000 | SEC↗ |